MeiraGTx Holdings MGTX
NASDAQ MGTX
$9.62 +0.13 (+1.37%)
At close: Nov 10, 2026 · 4:00 PM EST

MeiraGTx Holdings (MGTX) Gross Margin (2025 - 2026)

Updated

MeiraGTx Holdings (MGTX) reported Gross Margin of 97.77% for Q2 2026, up 70.27 percentage points from 27.50% a year earlier.

Analysis

MeiraGTx Holdings (MGTX) Gross Margin (2025 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 83.88%
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 68.12%
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 75.38%
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 72.95%
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 78.02%
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn 83.60%
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 73.10%
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 81.07%
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn 75.71%
10 MeiraGTx Holdings 878.99 Mn 583.51 Mn 314.27 Mn 97.77%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 97.77%
Jun 30, 2025 27.50%
API Access

MeiraGTx Holdings Gross Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-margin&ticker=MGTX&period=max&api_key=YOUR_API_KEY